Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N... ( BEIJING June 30 /Xinhua-- Sinovac...)

Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine

Date:6/30/2008

BEIJING, June 30 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the initiation of volunteer enrollment in its Phase II clinical trial for its split pandemic influenza vaccine. The preliminary results from this study are expected to be available in early 2009.

The randomized and double-blind trial is expected to enroll 210 adolescents, between the ages of 12 to 17, who will receive doses of 10ug, 15ug or 30ug, and 140 children, between the ages of 3 to 11, who will receive doses of 10ug or 15ug. Volunteers will be followed for two months with safety and immunogenicity data collected for the assessment of the vaccine.

Mr. Weidong Yin, Chairman, President and CEO, commented, ''Split influenza vaccine is believed to cause less adverse reactions in children compared to whole-viron influenza vaccine. Sinovac's split pandemic influenza vaccine aims at protecting the pediatric and adolescent population. Based on the positive safety results of the Phase I trial, the Phase II study will be conducted to further collect the vaccine's safety data in children and adolescents, as well as assessing the immunogenicity of different doses.''

Sinovac received approval from the China State Food and Drug Administration (SFDA) in April 2007 to conduct clinical trials for two types of the H5N1 vaccine, namely Phase Ib and II trials of the H5N1 whole viron vaccine and Phase I and Phase II trials of the H5N1 split vaccine. In December 2007, Sinovac reported positive top-line results from the completed Phase II clinical trial of Panflu(TM), its pandemic influenza (H5N1) whole viron inactivated vaccine. In April 2008, Panflu(TM) was granted a production license by the China State Food and Drug Administration (SFDA). Panflu(TM) is the first and only approved vaccine available in China against the H5N1 influenza virus.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
2. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
3. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
8. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
9. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. Prolexys Pharmaceuticals Initiates Phase 1 Study

Post Your Comments:

(Date:12/14/2009)... Fujirebio Diagnostics Inc., a Malvern-based diagnostics ... Year by the Eastern Technology Council at a ... Philadelphia on Thursday, December 3, 2009. ... region,s largest technology and life sciences trade association. ... and Life Sciences Community, the awards are a ...

(Date:12/14/2009)... Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced that ... Staccato® loxapine (AZ-004) to the US Food and Drug ... being developed for the rapid treatment of agitation in ... for Staccato loxapine was filed with the ... predictable and consistent safety and efficacy profile in treating ...

(Date:12/14/2009)... 14 Zargis Medical Corp., a majority-owned ... and a spin-off from Siemens Corporate Research (NYSE: ... has begun selling its award-winning Zargis Cardioscan(TM) system ... and its accompanying Bluetooth®-enabled electronic stethoscope were jointly ... "2009 Innovation of the Year." Cardioscan is ...

[0] Fujirebio Diagnostics Named Life Sciences Company of the Year [0] Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA [0] Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com

... 27 Immtech Pharmaceuticals,Inc. (Immtech) (Amex: IMM ... Drug,Administration of the People,s Republic of China (SFDA) ... a Phase III clinical,trial with pafuramidine, the Company,s ... (PCP). Pafuramidine is among the first,drugs to be ...

... Sept. 26 Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ... trial of glufosfamide plus gemcitabine were presented at ... Spain. In the Phase 2 clinical trial ... of advanced pancreatic cancer, six-month and,one-year survival were ...

Other Medicine Technology:Chinese SFDA Grants Immtech Fast Track Status 2 Chinese SFDA Grants Immtech Fast Track Status 3 Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2 Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3 Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4

Chinese SFDA Grants Immtech Fast Track Status Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO)

(Date:12/14/2009)... Kurth Krause, an aerospace engineer,for NASA, was giving ... moon, he,was confident that technology and science could ... was one thing that science couldn,t solve.,His wife ... dialysis machines,would keep her alive for awhile, she ... is 69 and is starting dialysis next month. ...

(Date:12/14/2009)... to scans performed in 2007 , , MONDAY, Dec. 14 ... to far more radiation than previously thought and in doses ... two new studies claim. , Based on the findings, reported ... Internal Medicine , the study authors, joined by Archives ... to limit radiation exposure to patients. , "CT has become ...

(Date:12/14/2009)... Decaf may also offer some protection, study finds, , , ... for people who can,t start their morning without a ... may decrease the risk of developing type 2 diabetes. ... that also found the more coffee you drink, the ... was associated with a 7 percent reduction in the ...

(Date:12/14/2009)... CHAPEL HILL -- Type 2 diabetes and obesity are ... Recently published studies suggested that insulin glargine (a synthetic ... be associated with a higher risk of certain cancers ... However, these studies were unable to control for important ... association. , On the other hand, a large ...

(Date:12/14/2009)... lead to better treatments for asthma, COPD, researchers say ... identified five genetic variants that influence lung function, a ... lung diseases. , The international team of researchers compared ... 2.5 million sites across the human genome in more ... team to the five common genetic variants associated with ...

Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2 Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3 Health News:Studies Quantify Cancer Risks From CT Scans 2 Health News:Studies Quantify Cancer Risks From CT Scans 3 Health News:Studies Quantify Cancer Risks From CT Scans 4 Health News:Coffee, Tea Might Stave Off Diabetes 2 Health News:Coffee, Tea Might Stave Off Diabetes 3 Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2

[0] 69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger [0] Studies Quantify Cancer Risks From CT Scans [0] Coffee, Tea Might Stave Off Diabetes [1] UNC scientists coordinate study of link between insulin use and cancer in people with diabetes [0] Five Gene Variants May Be Linked to Lung Disease

... Solta Medical, Inc. (Nasdaq: SLTM ), a ... it will release its financial results for the first quarter ... May 5, 2009. The Company will also host a ... 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the ...

... N.C., April 27 Susan Brady of ... professionals in the nation to become certified by ... nonprofit organization that provides advocacy and education for ... demonstrated in-depth knowledge and expertise on best practices ...

... According to new research reported in the ... casei strain Shirota may ease symptoms of anxiety ... Thirty-nine patients with CFS received daily supplements of ... two months. Compared to the placebo group, ...

... at Telemedicine Conference in Las Vegas, Booth 1206 LAS ... Suisse AG (Fora Care,s Swiss sister company) announced today ... American Telemedicine Association (ATA) conference through April 28 at ... The veteran telemedicine companies are presenting at the ...

... following is being issued by American Stroke Association: , , ... It,s better to find out than miss out. Be aware ... and their side effects. Ask if your home should be modified ... doctor, nurse or therapist to clarify any unanswered questions or to ...

... April 27 Daily exposure to toxins in the ... adhesives, and insecticides, are creating a toxic load on ... and asthma. In light of increased awareness of our ... ) announced today the release of three ...

Other Medicine News:Health News:Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call 2 Health News:MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development 2 Health News:New Study Shows Supplementing With Probiotics May Ease Anxiety 2 Health News:Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 2 Health News:Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 3 Health News:15 Tips Caregivers Should Know After a Loved One Has Had a Stroke 2 Health News:15 Tips Caregivers Should Know After a Loved One Has Had a Stroke 3 Health News:Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health 2

Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development New Study Shows Supplementing With Probiotics May Ease Anxiety Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 15 Tips Caregivers Should Know After a Loved One Has Had a Stroke Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health

Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....

CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....

... Techno-Aide provides the highest level ... highest quality lead protective eyewear. ... + tolerance allowed. Mfg supervised by ... All lens meet or exceed standards ...

This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....

Medicine Products:

Turnstile Casting Stand™CEMEX Fast Set The LITE STYLE Clip-On

Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N...( BEIJING June 30 /Xinhua-- Sinovac...),Health